Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls: A longitudinal cohort study

Sexually Transmitted Diseases

Volumn 23, Issue 3, 1996, Pages 234-238

  Andersson Ellström, Agneta ^a,g   Dillner, Joakim ^b   Hagmar, Björn ^c   Schiller, John ^d   Sapp, Martin ^e   Forssman, Lars ^f   Milsom, Ian ^f  

^a Centre for Public Health Research Karlstad   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g Gynmottagninggen   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; COHORT ANALYSIS; COITUS; COMPARATIVE STUDY; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS TRANSMISSION; WART VIRUS;

EID: 0029990732     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-199605000-00013     Document Type: Article

References (32)

1. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85:958-964.
2. Zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991; 184:9-13.
3. Brinton LA, Hamman RF, Huggins OR, et al. Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst 1987; 79:23-30.
4. Sadeghi SB, Hsieh EW, Gunn SW. Prevalence of cervical intraepithelial neoplasia in sexually active teenagers and young adults. Am J Obstet Gynecol 1984; 148:726-729.
5. Shy K, Chu J, Mandelson M, Greer B, Figge D. Papanicolaou smear screening interval and risk of cervical cancer. Obstet Gynecol 1989; 74:838-843.
6. Moscicki AB, Palefsky J, Gonzales J, Schoolnik GK. Human papillomavirus infection in sexually active adolescent females: Prevalence and risk factors. Pediatr Res 1990; 28:507-513.
7. Ley C, Bauer HM, Reingold A, et al. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 1991; 83:997-1003.
8. Hildesheim A, Gravitt P, Schiffman MH, et al. Determinants of genital human papillomavirus infection in low-income women in Washington, DC. Sex Transm Dis 1993; 20:279-285.
9. Evander M, Edlund K, Gustafsson Å, et al. Human papillomavirus infection is transient in young women: A population based cohort study. J Infect Dis 1995; 171: 1026-1030.
10. Pakarian F, Kaye J, Cason J, et al. Cancer associated human papillomaviruses: Perinatal transmission and persistence. Br J Obstet Gynecol 1994; 101:514-517.
11. Jenison SA, Yu XP, Valentine JM, et al. Evidence of prevalent genital-type human papillomavirus infections in adults and children. J Infect Dis 1990; 162:60-69.
12. Pao CC, Tsai PL, Chang YL, Hsieh TT, Jin JY. Possible non-sexual transmission of genital human papillomavirus infections in young women. Eur J Clin Microbiol Infect Dis 1993; 12:221-222.
13. Fairley CK, Chen S, Tabrizi SN, Leeton K, Quinn MA, Garland SM. The absence of genital human papillomavirus DNA in virginal women. Im J STD AIDS 1992; 3:414-417.
14. Rylander E, Ruusuvaara L, Almströmer MW, Evander M, Wadell G. The absence of vaginal human papillomavirus 16 DNA in women who have not experienced sexual intercourse. Obstet Gynecol 1994; 83:735-737.
15. Jochmus-Kudielka I, Schneider A, Braun R, et al. Antibodies against the human papillomavirus type 16 early proteins in human sera: Correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst 1989; 81:1968-1704.
16. Moscicki AB, Palefsky J, Smith G, Siboshski S, Schoolnik G. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol 1993; 82:578-585.
17. Rosenfeld WD, Rose E, Vermund SH, Schreiber K, Burk RD. Follow-up evaluation of cervicovaginal human papillomavirus infection in adolescents. J Pediatr 1992; 121:307-311.
18. Van Doornum GJJ, Prins M, Juffermans LHJ, et al. Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: A prospective study. Genitourin Med 1994; 70:240-246.
19. Hildesheim A, Schiffman MH, Gravitt PE, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994; 169:235-240.
20. Andersson-Ellström A, Dillner J, Hagmar B, Schiller J, Forssman L. No serological evidence for non-sexual spread of HPV16. Lancet 1994; 344:1435. Letter.
21. Skyldberg B, Hagmar B, Johansson B, et al. HPV detection in cytological cases with condylomatous or dysplastic changes: A study with PCR and in situ hybridization on cytologic material. Diagn Cytopathol 1995; 13:8-14.
22. Skyldberg B, Kalantari M, Karki M, Johansson B, Hagmar B, Walaas L. Detection of human papillomavirus infection in tissue blocks by in situ hybridization as compared with a polymerase chain reaction procedure. Hum Pathol 1991; 22:578-582.
23. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR. Use of polymerase chain reaction amplification for the detection of human papillomaviruses. Cancer Cells 1989; 7:209-221.
24. Erlich HA, Bugawan TL. HLA class II gene polymorphism. In: Erlich HA, ed. DNA Typing Evolution and Relationship to Disease Susceptibility: PCR Technology, Principles and Applications for DNA Amplification. New York: Stockton Press, 1989; 193-208.
25. Heino P, Eklund C, Fredriksson-Shahnazarian V, et al. Association of serum IgG antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma. J Natl Cancer Inst 1995; 87:437-440.
26. Kirnbauer R, Hubbert NL, Wheeler CM, et al. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 1994; 86:494-498.
27. Volpers C, Schirmacher P, Streeck RE, Sapp M. Assembly of the major and the minor capsid protein ot human papillomavirus type 33 into virus-like particles and tubular structures in insect cells. Virology 1994; 200:504-512.
28. Andersson-Ellström A, Hagmar B, Johansson B, Kalantari M, Wärleby B, Forssman L. Human papillomavirus deoxyribonucleic acid in cervix only detected in girls after coitus. Int J STD AIDS. 1996; in press.
29. Wheeler CM, Parmenter CA, Hunt WC, et al. Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center. Sex Transm Dis 1993; 20:286-289.
30. Sherman ME, Schiffman MH, Lorincz AT, et al. Toward objective quality assurance in cervical cytopathology: Correlation of cytopathologic diagnosis with detection of high-risk human papillomavirus types. Am J Clin Pathol 1994; 102:182-187.
31. Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991; 265:472-477.
32. Kirnbauer R, Taub J, Greenstone H, et al. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol 1993; 67:6929-6936.